CSN5 overexpression promotes the integral progression of cervical cancer by enhancing ENO3-mediated glycolysis
Open Access
- 12 January 2026
- journal article
- research article
- Published by Springer Nature in Apoptosis
- Vol. 31 (1) , 41
Abstract
Cervical cancer (CC) remains a significant global health challenge. A deeper understanding of the molecular mechanisms driving CC progression is crucial for developing improved therapeutic strategies. CSN5 is vital in cell functions and cancer, but its role in CC is unclear. This study aims to explore CSN5’s role and its target gene in CC progression, assessing their potential as therapeutic targets. We employed an integrated approach combining bioinformatics analysis, proteomic profiling, and in vitro and in vivo functional assays. Immunohistochemistry was used to analyze CSN5 and ENO3 expression in CC and normal tissues. CSN5 upregulation was associated with advanced clinical stage and poor differentiation. Furthermore, CSN5 overexpression enhanced cellular proliferation and glycolytic metabolism but, paradoxically, suppressed migration, invasion, and the epithelial-mesenchymal transition (EMT). These pro-tumorigenic effects were confirmed in vivo, and the glycolytic inhibitor 2-DG was found to reverse the phenotypes induced by CSN5. Protein sequencing highlighted ENO3’s role in CSN5-mediated tumorigenesis, regulating EMT and glycolysis by stabilizing its ubiquitination degradation through CSN5. Crucially, silencing ENO3 attenuated the oncogenic effects of CSN5 both in vitro and in vivo. Our findings unveil a novel mechanistic paradigm in which CSN5 promotes CC progression by co-opting ENO3 to enhance glycolytic flux while concurrently suppressing cell motility. This study not only deepens the understanding of CC pathogenesis but also identifies the CSN5-ENO3 axis as a promising target for novel therapeutic interventions. Graphical abstractKeywords
Funding Information
- Natural Science Foundation of Zhejiang Province (No. LQ20H160054)
- Natural Science Foundation of Zhejiang Province (No. LQ20H160049)
- Natural Science Foundation of Zhejiang Province (No. LQ20H040009)
- Natural Science Foundation of Zhejiang Province (No. LTGY23H160022)
- Natural Science Foundation of China (NO. 82103200)
- The National Key R&D Program of China (Grant number 2021YFC2701204)
This publication has 57 references indexed in Scilit:
- Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).2003
- Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma.2003
- Human Papillomavirus and Cervical CancerClinical Microbiology Reviews, 2003
- Jab1 Interacts Directly with HIF-1α and Regulates Its StabilityJournal of Biological Chemistry, 2002
- The Cytoplasmic Shuttling and Subsequent Degradation of p27Kip1 Mediated by Jab1/CSN5 and the COP9 Signalosome ComplexJournal of Biological Chemistry, 2002
- Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.2001
- Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of developmentTrends in Genetics, 2000
- Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1Nature, 1999
- Arabidopsis Homologs of a c-Jun Coactivator Are Present Both in Monomeric Form and in the COP9 Complex, and Their Abundance Is Differentially Affected by the Pleiotropic cop/det/fus MutationsThe Plant Cell, 1998
- A new group of conserved coactivators that increase the specificity of AP-1 transcription factorsNature, 1996